A Thorough QT Study of TR-701free Acid (FA) in Healthy Subjects
Clinical trial NCT01461460 · COMPLETED
Trial details
- NCT number
- NCT01461460
- Sponsor
- Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-28
- Primary completion
- 2011-12-23
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.